Cytokinetics, Incorporated financial statements
Cytokinetics, Incorporated's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 88.04M | 10-K |
| Net income | −USD 784.96M | 10-K |
| Cash and equivalents | USD 122.52M | 10-Q |
| Total debt | USD 287.56M | 10-Q |
Cytokinetics, Incorporated financials on 6ix · Cytokinetics, Incorporated on 6ix